Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 OCT 20 ... presented today during the 21st Annual Clean Air Awards luncheon hosted by AQMD at the Millennium Biltmore Hotel in Downtown Los Angeles. Dr. Bruce Hensel, award-winning medical, health ... Ecology, Environment, Technology, Transportation Service, Drugs, Patents Actions, Pharmaceuticals, Sulfur, Therapy, Treatment This article was prepared by Drug Law Weekly ...
2009 NOV 16 ... responds poorly to current chemotherapies. The drug, a proteasome inhibitor developed by Millennium Pharmaceuticals and Johnson & Johnson, was approved by the FDA for the treatment of a rare, aggressive ...
2009 NOV 16 ... According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, ... insights. Keywords: Atrial Fibrillation, Cardiology, Electrophysiology, Pharmaceuticals, Pharmacological, Pharmacotherapy, Stroke, Therapy, Treatment, Millennium Research ...
2009 NOV 23 ... Life Line Screening, Mayo Clinic, Memorial Sloan-Kettering Cancer Center, Merck, Millennium, Otsuka, sanofi-aventis, and UCB. Heartbeat Digital publishes a daily blog ... healthcare clients include Amgen, Auxilium, Bayer, Becton Dickinson, Cephalon, Endo Pharmaceuticals, Life Line Screening, Mayo Clinic, Memorial Sloan-Kettering Cancer Center, Merck, ...
2009 NOV 9 ... announced that Marsha Fanucci has joined its Board of Directors. Ms. Fanucci served at Millennium Pharmaceuticals, Inc. from 2000-2009 in a number of senior positions, including chief financial officer ...
2009 NOV 2 ... mostly affecting those above 50 years of age. About VELCADE VELCADE is co-developed by Millennium Pharmaceuticals, Inc. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Millennium is ...
2009 NOV 23 ... Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to ... Opiate Agonist, Oxycodone Hydrochloride, Oxycontin, Pain Management, Pain Medicine, Pharmaceuticals, Physiology, Therapy, Treatment, Millennium Laboratories. This article was ...
2009 NOV 16 ... Times' Global Pharmaceutical and Biotechnology Conference, which will be held at the Millennium Mayfair Hotel in London on November 17-18, 2009. Mr. Ede will present as a ... visit http://www.ftconferences.com/pharmabio . Keywords: Biotechnology, Pharmaceuticals, Therapy, Treatment, Mindray Medical International Limited. This article ...
2009 NOV 23 ... be obtained by contacting J. George, University of Sydney, Storr Liver Unit, Westmead Millennium Institute, Sydney, NSW 2006, Australia. The publisher of the journal Nature ... Gastroenterology, HCV, Hepatitis C Virus, Hepatology, Infectious Disease, Interferon, Pharmaceuticals, Ribavirin, Treatment, Virology, University of Sydney. This article was ...
2009 OCT 19 ... Bayer, CuraGen, Progenics, Daiichi Sankyo, MedImmune, a subsidiary of AstraZeneca, and Millennium: The Takeda Oncology Company, as well as an ADC co-development agreement with Agensys, a ... Immunosuppressant, Medical Device, Monoclonal Antibodies, Monoclonal Antibody, Oncology, Pharmaceuticals, Radiation-Sensitizing Agent, Rituxan, Rituximab, Solid Cancers, Solid Carcinomas, ...
2009 NOV 2 ... Therapeutics, Progenics, Daiichi Sankyo, MedImmune, a subsidiary of AstraZeneca, and Millennium: The Takeda Oncology Company, as well as an ADC co-development agreement with Agensys, a ... Multiple Myeloma, Myeloma, Oncology, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Pre-Trials Research, Radiation-Sensitizing Agent, Regulatory Actions, Revlimid, Solid ...
2009 NOV 1 ... Bayer, CuraGen, Progenics, Daiichi Sankyo, MedImmune, a subsidiary of AstraZeneca, and Millennium: The Takeda Oncology Company, as well as an ADC co-development agreement with Agensys, a ... Marketing and Licensing Agreements, Medical Device, Monoclonal Antibodies, Oncology, Pharmaceuticals, Taxotere, Therapy, Trastuzumab, Treatment, Seattle Genetics Inc. This ...
2009 NOV 16 ... 2009;52(9-10):355-359). For more information, contact Y.X. Li, Millennium Pharmaceutical Inc., Dept. of Drug Metab & Pharmacokinet, Takeda Oncology Co., Isotope ... Keywords: United States, Cambridge, Enzyme Research, Enzymes, Kinase, Pharmaceuticals, Therapy, Treatment. This article was prepared by Biotech Business Week ...
2009 NOV 24 ... experience within the biopharmaceutical industry, including Coley Pharmaceuticals and Millennium Pharmaceuticals. Prior to joining industry, Dr. Himes held academic positions at the National Institutes ...
2009 NOV 9 ... Supported by an educational grant from Millennium Pharmaceuticals, Inc., Centocor Ortho Biotech Services, LLC, Ortho Biotech, a division of Janssen Cilag, ...
2009 NOV 9 ... ) (1) Includes UniSource Energy on a stand-alone basis and results from Millennium Energy Holdings, Inc. and UniSource Energy Development, wholly owned subsidiaries of ... Renewable Energy, Stock Market, Tucson Electric Power, Unisource Energy, Copper, Drugs, Pharmaceuticals, Therapy, Treatment. This article was prepared by Biotech Business Week ...
